Atea Pharmaceuticals's chart data is dated 2026-10-09. There is no active technical signal. There are 0 published signal records.
Atea Pharmaceuticals last closed at $5.15 (-0.10%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -2.5×. Its overall grade ranks 339 of 738 stocks in Healthcare.
About this company
Atea Pharmaceuticals last closed at $5.15 (-0.10%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B · 339/738
Valuation grade B+
Related stocks
- NovartisCustomer
Atea의 주요 HCV(간염 C) 치료제 협업·상업화 파트너로 알려진 대형 제약사
- RocheCustomer
Atea의 HCV 후보물질 개발/상업화 협력 대상이었던 글로벌 제약사
- Merck & Co.Competitor
항바이러스·감염병 치료제 개발에서 경쟁하는 대형 제약사
About Atea Pharmaceuticals
- What technical signals does Atea Pharmaceuticals (AVIR) have?
- Atea Pharmaceuticals current technical signals: no active technical signal.
- Is Atea Pharmaceuticals a cup-and-handle pattern?
- No. Atea Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Atea Pharmaceuticals?
- Market cap: $402.35M. Trailing 12 months PER: -2.5×. Latest quarter PBR: 2.02×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Atea Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.